How to Treat Breast Hyperplasia

Breast hyperplasia—often referred to as fibrocystic breast changes—is a common, benign condition characterized by the noncancerous proliferation of glandular and stromal tissue in the breast. It typically presents with cyclic breast tenderness, lumpiness, or nodularity, most often worsening before menstruation and improving afterward. While not a disease per se, it reflects hormonal fluctuations, particularly estrogen-progesterone imbalances, and is especially prevalent among women of reproductive age.

Management focuses on symptom relief and reassurance rather than “cure,” since breast hyperplasia is physiologic in nature and carries no increased risk of breast cancer. First-line approaches include lifestyle modifications: reducing caffeine and high-fat dietary intake, wearing well-fitted supportive bras, and applying warm compresses for discomfort. Over-the-counter analgesics such as ibuprofen or acetaminophen may be used for pain control.

In cases of persistent or severe symptoms, hormonal modulation may be considered. Selective estrogen receptor modulators (SERMs) like tamoxifen—though rarely used due to side-effect profiles—are reserved for refractory cases under specialist supervision. Danazol, an attenuated androgen, has demonstrated efficacy but is limited by androgenic side effects and is seldom employed today. Vitamin E and evening primrose oil have been studied anecdotally, but robust clinical evidence supporting their routine use remains lacking.

Crucially, all patients should undergo thorough clinical breast examination and, when indicated, imaging—such as diagnostic ultrasound or mammography—to rule out malignancy or other pathologies. Any new, dominant, noncyclic, or fixed mass warrants prompt evaluation, including possible biopsy. Regular surveillance and patient education about breast self-awareness—not routine self-examination—are recommended to support early detection of concerning changes.